16.25
+0.79(+5.11%)
Currency In USD
| Previous Close | 15.46 |
| Open | 15.29 |
| Day High | 16.59 |
| Day Low | 15.29 |
| 52-Week High | 25.03 |
| 52-Week Low | 6.4 |
| Volume | 246,537 |
| Average Volume | 225,380 |
| Market Cap | 394.29M |
| PE | -6.04 |
| EPS | -2.69 |
| Moving Average 50 Days | 14.68 |
| Moving Average 200 Days | 11.11 |
| Change | 0.79 |
If you invested $1000 in CVRx, Inc. (CVRX) since IPO date, it would be worth $580.36 as of February 05, 2025 at a share price of $16.25. Whereas If you bought $1000 worth of CVRx, Inc. (CVRX) shares 3 years ago, it would be worth $1,950.78 as of February 05, 2025 at a share price of $16.25.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
GlobeNewswire Inc.
Jan 21, 2025 9:30 PM GMT
MINNEAPOLIS, Jan. 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
GlobeNewswire Inc.
Jan 13, 2025 1:00 PM GMT
Fourth quarter revenue expected to be $15.2 million to $15.3 million, representing growth of 35%Full year revenue expected to be $51.1 million to $51.2 million, representing growth of 30%Fiscal 2025 revenue expected to be between $63.0 million and $6
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 23, 2024 9:30 PM GMT
MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, J